A detailed history of Hhlr Advisors, Ltd. transactions in Pacific Biosciences Of California, Inc. stock. As of the latest transaction made, Hhlr Advisors, Ltd. holds 918,892 shares of PACB stock, worth $2.31 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
918,892
Previous 918,892 -0.0%
Holding current value
$2.31 Million
Previous $3.45 Million 63.48%
% of portfolio
0.03%
Previous 0.08%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023

BUY
$8.23 - $13.93 $7.56 Million - $12.8 Million
918,892 New
918,892 $7.67 Million
Q4 2021

Feb 14, 2022

SELL
$19.26 - $30.08 $17.5 Million - $27.4 Million
-911,039 Closed
0 $0
Q3 2021

Nov 15, 2021

BUY
$24.86 - $35.02 $22.6 Million - $31.9 Million
911,039 New
911,039 $23.3 Million

Others Institutions Holding PACB

About PACIFIC BIOSCIENCES OF CALIFORNIA, INC.


  • Ticker PACB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 224,840,992
  • Market Cap $564M
  • Description
  • Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing systems to resolve genetically complex problems. The company provides PacBio's Systems, which conduct, monitor, and analyse biochemical sequencing reactions; consumable products, including single molecule real-time (SMRT) cells; and various reagent kits design...
More about PACB
Track This Portfolio

Track Hhlr Advisors, Ltd. Portfolio

Follow Hhlr Advisors, Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hhlr Advisors, Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Hhlr Advisors, Ltd. with notifications on news.